Tesamorelin 5 mg Certificate of Analysis
- Product
- Tesamorelin 5 mg
- Report number
- CPT-TESAMO-C75B8F
- Batch / lot
- L25-01 · CGX-2025
- Tested
- Sep 28, 2026
- Reported
- Oct 2, 2026
- Laboratory
- Canada Peptide Testing (independent)
- Method
- HPLC-UV purity and content
- Reported purity
- 99.18%
- Measured content
- 5.19 mg (expected 5.00 mg)
- Fill accuracy
- 103.8%
How to read this certificate
- Report number: the lab’s ID for this test. The QR code on the certificate and the Verify button open the same record on canadapeptidetesting.com.
- HPLC purity: the share of the main compound among everything the chromatography column detected in the sample.
- Content: the measured amount of compound in the vial, compared with the labelled amount.
- Tested date: when the lab ran the sample. Each lot is tied to its own report.
About Tesamorelin
An analogue of the full 44-residue growth-hormone-releasing hormone with a trans-3-hexenoyl group at the N-terminus.
Formula C221H366N72O67S · MW 5136 g/mol · CAS 218949-48-5
Related certificates
Reported results apply to the tested lot. For research use only. Not for use in diagnostic or therapeutic procedures.
